These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11822352)

  • 1. The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats.
    Calvente PR; Araujo CC; Bergamo M; Abilio VC; D'Almeida V; Ribeiro Rde A; Frussa FR
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):401-5. PubMed ID: 11822352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age on a new animal model of tardive dyskinesia.
    Bergamo M; Abílio VC; Queiroz CM; Barbosa-Júnior HN; Abdanur LR; Frussa-Filho R
    Neurobiol Aging; 1997; 18(6):623-9. PubMed ID: 9461060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.
    Ouary S; Bizat N; Altairac S; Ménétrat H; Mittoux V; Condé F; Hantraye P; Brouillet E
    Neuroscience; 2000; 97(3):521-30. PubMed ID: 10828534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of monosialoganglioside on a new model of tardive dyskinesia.
    Vital MA; Frussa-Filho R; Palermo-Neto J
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Oct; 21(7):1169-79. PubMed ID: 9421829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of buspirone on an animal model of tardive dyskinesia.
    Queiroz CM; Frussa-Filho R
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Nov; 23(8):1405-18. PubMed ID: 10631766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebselen attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum.
    Burger ME; Alves A; Callegari L; Athayde FR; Nogueira CW; Zeni G; Rocha JB
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):135-40. PubMed ID: 12551736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide.
    Burger M; Fachinetto R; Calegari L; Paixão MW; Braga AL; Rocha JB
    Brain Res Bull; 2004 Dec; 64(4):339-45. PubMed ID: 15561469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gabaergic drugs on reserpine-induced oral dyskinesia.
    Peixoto MF; Araujo NP; Silva RH; Castro JP; Fukushiro DF; Faria RR; Zanier-Gomes PH; Medrano WA; Frussa-Filho R; Abílio VC
    Behav Brain Res; 2005 May; 160(1):51-9. PubMed ID: 15836900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topiramate on oral dyskinesia induced by reserpine.
    Araujo NP; Abílio VC; Silva RH; Pereira RC; Carvalho RC; Gonzalez C; Bellot RG; Castro JP; Fukushiro DF; Rodrigues MS; Chinen CC; Frussa-Filho R
    Brain Res Bull; 2004 Dec; 64(4):331-7. PubMed ID: 15561468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia.
    Neisewander JL; Castañeda E; Davis DA
    Psychopharmacology (Berl); 1994 Sep; 116(1):79-84. PubMed ID: 7862934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reserpine does not induce orofacial dyskinesia in spontaneously hypertensive rats.
    Queiroz CM; Piovezan RD; Frussa-Filho R
    Eur J Pharmacol; 1998 Sep; 356(2-3):105-8. PubMed ID: 9774239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats.
    Abílio VC; Araujo CC; Bergamo M; Calvente PR; D'Almeida V; Ribeiro Rde A; Frussa-Filho R
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):109-14. PubMed ID: 12551732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats.
    Burger ME; Fachineto R; Alves A; Callegari L; Rocha JB
    Brain Res; 2005 Jan; 1031(2):202-10. PubMed ID: 15649445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute reserpine administration elicits long-term spontaneous oral dyskinesia.
    Sussman AN; Tran-Nguyen LT; Neisewander JL
    Eur J Pharmacol; 1997 Oct; 337(2-3):157-60. PubMed ID: 9430409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats.
    Pereira RP; Fachinetto R; de Souza Prestes A; Wagner C; Sudati JH; Boligon AA; Athayde ML; Morsch VM; Rocha JB
    J Neural Transm (Vienna); 2011 Nov; 118(11):1547-57. PubMed ID: 21476069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallic acid decreases vacuous chewing movements induced by reserpine in rats.
    Reckziegel P; Peroza LR; Schaffer LF; Ferrari MC; de Freitas CM; Bürger ME; Fachinetto R
    Pharmacol Biochem Behav; 2013 Mar; 104():132-7. PubMed ID: 23313549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mitochondrial toxin 3-nitropropionic acid induces vacuous chewing movements in rats. Implications for tardive dyskinesia?
    Andreassen OA; Jørgensen HA
    Psychopharmacology (Berl); 1995 Jun; 119(4):474-6. PubMed ID: 7480528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction.
    Naidu PS; Singh A; Kulkarni SK
    Phytother Res; 2006 Feb; 20(2):140-6. PubMed ID: 16444668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid.
    Andreassen OA; Ferrante RJ; Beal MF; Jørgensen HA
    Neuroscience; 1998 Dec; 87(3):639-48. PubMed ID: 9758230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of MK-801 on reserpine-treated mice.
    Dutra RC; Andreazza AP; Andreatini R; Tufik S; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):487-95. PubMed ID: 11999899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.